Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?

por Gascón, Marta, Isla, Dolores, Cruellas, Mara, Gálvez, Eva M., Lastra, Rodrigo, Ocáriz, Maitane, Paño, José Ramón, Ramírez, Ariel, Sesma, Andrea, Torres-Ramón, Irene, Yubero, Alfonso, Pardo, Julián, Martínez-Lostao, Luis
Publicado 2020

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

por Ocáriz-Díez, Maitane, Cruellas, Mara, Gascón, Marta, Lastra, Rodrigo, Martínez-Lostao, Luis, Ramírez-Labrada, Ariel, Paño, José Ramón, Sesma, Andrea, Torres, Irene, Yubero, Alfonso, Pardo, Julián, Isla, Dolores, Gálvez, Eva M.
Publicado 2020

From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy

por Sesma, Andrea, Pardo, Julián, Cruellas, Mara, Gálvez, Eva M., Gascón, Marta, Isla, Dolores, Martínez-Lostao, Luis, Ocáriz, Maitane, Paño, José Ramón, Quílez, Elisa, Ramírez, Ariel, Torres-Ramón, Irene, Yubero, Alfonso, Zapata, María, Lastra, Rodrigo
Publicado 2020